Abstract
The infection of COVID-19 has caused a global pandemic. In order to avoid excessive restriction to the social activity, a good strategy of quarantine based on a realistic model is expected. Several epidemic models with a quarantine compartment such as susceptible-exposed-infectious-quarantined-recovered (SEIQR) model have been applied. However, in the actual situation, the infection test and quarantine is often delayed from the beginning of the infectious stage.
This article presents a delayed SEIQR model to analyze the effect of the delay of quarantine. The latency period (compartment E) and the incubation period were assumed to be 3 days and 5 days, respectively. Considering that the presymptomatic infection ratio is 0.4, the natural decay rate of the number of infectious patients was assumed to be 0.25 days-1. The recovery rate was assumed to be 0.07 days-1 from the typical PCR test positive period. The PCR test positive number in the period from March 10 to July 18 in 2020 in Tokyo area was analyzed. The delay time distribution of the quarantine was derived from the record of the symptom onset date, and was utilized to determine the delay time profile of quarantine in the model.
It was found that the major contributor to the infection control was the restraint of social contact. However, the quarantine action also contributed to reducing the reproduction number by the ratio of 0.88 and 0.8 in the period from March 10 to June 3 and from June 4 to July 18, respectively. The delay of quarantine was found to be well correlated to the effectiveness of quarantine. Therefore, a record on a symptom onset date is very important to estimate the effect of quarantine measure. The basic reproduction number was estimated to be 2.56. In view of the presymptomatic infection ratio 0.4, it would be very hard to restrain the expansion of infection only by quarantining the symptomatic patients.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
There is no clinical trial.
Funding Statement
The author received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos